Chargement en cours...
Development of Injectable PEGylated Liposome Encapsulating Disulfiram for Colorectal Cancer Treatment
Disulfiram (DS), an anti-alcoholism medicine, shows strong anti-cancer activity in the laboratory, but the application in clinics for anti-cancer therapy has been limited by its prompt metabolism. Conventional liposomes have shown limited ability to protect DS. Therefore, the aim of this study is to...
Enregistré dans:
| Publié dans: | Pharmaceutics |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6920821/ https://ncbi.nlm.nih.gov/pubmed/31739556 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics11110610 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|